.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Julphar
UBS
Moodys
Colorcon
Deloitte
Harvard Business School
Daiichi Sankyo
Teva
US Department of Justice

Generated: December 16, 2017

DrugPatentWatch Database Preview

RIVASTIGMINE Drug Profile

« Back to Dashboard

When do Rivastigmine patents expire, and what generic alternatives are available?

Rivastigmine is a drug marketed by Alvogen Malta, Ajanta Pharma Ltd, Alembic Pharms Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Dr Reddys Labs Inc, Macleods Pharms Ltd, Orchid Hlthcare, Sun Pharm Inds Ltd, and Watson Labs. and is included in eleven NDAs.

The generic ingredient in RIVASTIGMINE is rivastigmine tartrate. There are thirty-two drug master file entries for this compound. Twenty suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the rivastigmine tartrate profile page.
Drug patent expirations by year for RIVASTIGMINE

Pharmacology for RIVASTIGMINE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson LabsRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL077129-002Jan 8, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Orchid HlthcareRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL090879-001Jun 10, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms LtdRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL203148-001Aug 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Orchid HlthcareRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL090879-002Jun 10, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms LtdRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL203148-002Aug 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen MaltaRIVASTIGMINErivastigmineFILM, EXTENDED RELEASE;TRANSDERMAL204403-001Sep 3, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL204572-003Mar 25, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs IncRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL077130-001Oct 31, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL077131-004Oct 22, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Ajanta Pharma LtdRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL207797-004Sep 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Baxter
Merck
Cerilliant
Medtronic
UBS
Fish and Richardson
Healthtrust
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot